Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Loci Link Plasma Lipid Levels to CVD Risk

By LabMedica International staff writers
Posted on 07 Oct 2019
A team of Finnish and international researchers utilized both genomics and lipidomics approaches to identify novel genetic variants associated with plasma levels of lipid species and linked these levels to cardiovascular disease (CVD) risk.

The lipidome refers to the totality of lipids in cells. More...
The human plasma lipidome consists of almost 600 distinct molecular species. Research results have suggested that the lipidome of an individual may be able to indicate cancer risks associated with dietary fats, particularly breast cancer.

While some plasma lipids such as cholesterol and triglycerides are well-established heritable risk factors for CVD, hundreds of other lipid species are known risk factors for cardiovascular disease but have not been well characterized. In this regard, investigators at the University of Helsinki (Finland) and their collaborators sought to establish links between lipid levels and cardiovascular disease risk. Specifically, they aimed to (1) determine heritability of lipid species and their genetic correlations; (2) identify genetic variants influencing the plasma levels of lipid species; (3) test the relationship between identified lipid–species-associated variants and CVD manifestations and (4) gain mechanistic insights into established lipid variants.

For this study, they performed genome-wide association analyses of 141 lipid species (in 2,181 individuals), followed by phenome-wide scans with 25 CVD related phenotypes of 511,700 individuals.

Results showed that the scans had identified 35 lipid-species-associated loci, 10 of which associated with CVD risk including five new loci. Furthermore, they found that lipoprotein lipase (LPL) more efficiently hydrolyzed medium length triacylglycerides (TAGs) than others. Polyunsaturated lipids had the highest heritability and genetic correlations, suggesting considerable genetic regulation at fatty acids levels.

"Our study demonstrates that lipidomics enables much deeper insights into the genetic regulation of lipid metabolism. We hope that the openly available browser will in part help future biomarker and drug target discovery and build our understanding of the pathways connecting genetic variation to cardiovascular and other lipid-related diseases", said senior author Dr. Samuli Ripatti, professor of biometry at the University of Helsinki.

The study was published in the September 24, 2019, online edition of the journal Nature Communications and the data are freely available on the Internet at https://mqtl.fimm.fi.

Related Links:
University of Helsinki


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.